• Title/Summary/Keyword: 생존기간

Search Result 1,570, Processing Time 0.038 seconds

Analysis for Survival Factors in the Cultural Contents Industry (문화콘텐츠산업의 생존요인에 관한 분석)

  • Kim, Tae-Hun
    • The Journal of the Korea Contents Association
    • /
    • v.12 no.2
    • /
    • pp.255-264
    • /
    • 2012
  • This paper analyzes the survival rate of small & medium size-cultural contents industry, which includes printing, broadcasting, advertising, entertainment, other manufactures, and so on, by using survival analysis. In this article, after testing significance among characteristic factors and survival rate and hazard rate were estimated The results of the analysis are as follows: There are some significants differences among industries in details. Also there are some significants differences by region, by the number of employees, by financial status, and working periods of CEOs. The contribution of this study is to apply the method of survival analysis to the cultural contents industry in Korea.

국내 해양환경에 적합한 익수자 생존시간 산정에 관한 연구

  • 정해상;정다운;윤종휘;김충기
    • Proceedings of the Korean Institute of Navigation and Port Research Conference
    • /
    • 2023.11a
    • /
    • pp.54-56
    • /
    • 2023
  • 해양 수색구조 시나리오 수립 시 익수자 생존시간은 의사 결정을 하는 데 있어 중요한 고려 사항이다. 이 연구에서는 국내 보도자료와 설문조사 및 해외 생존모델을 참고하여 수색자원을 신속하고 집중적으로 투입해야하는 집중 수색기간과 생존 가능성을 고려하여 수색을 유지해야하는 추천 수색시간을 정할 때 참고할만한 익수자 생존시간 지표를 개발하였다.

  • PDF

Comparative Analysis of Survival Period by Technological Capabilities of Innovative SMEs in the Service Industry (기술수준에 따른 서비스업 혁신 중소기업의 생존기간 비교분석)

  • Lee, Jun-won
    • Korean small business review
    • /
    • v.43 no.3
    • /
    • pp.1-20
    • /
    • 2021
  • The survival period according to technological capability was analyzed for about 22,500 innovative SMEs in the service industry. The survival period was defined as the occurrence of overdue and default, and the technological capability was divided into two clusters. As a result of estimating the survival period according to technological capability through Kaplan-Meier analysis, it was confirmed that the estimated survival period of T1-T4 grade service innovative SMEs was significantly greater in both overdue and default. As a result of the analysis of the Cox proportional hazard model applying the control variable, it was confirmed that the higher technological capability, the lower the risk in the group of start-up companies. However, in the group of non-start-up companies the technological capability did not significantly affect the survival period, and the influence of the variables related to the size of the company was found to increase. Therefore, the technological capability is meaningful as additional information that has a significant effect on the survival period of innovative SMEs in the start-up companies group of service industry. In addition, it was concluded that it is necessary to reflect the technological capability when establishing the SME support and promotion policy of the start-up companies group in the service industry.

Relationship between DNA ploidy and Survival Time in Small Cell Lung Cancer (소세포 폐암에서 DNA 배수성과 생존 기간과의 관계)

  • Song, Joong-Ho;Yang, Se-Hoon;Jung, Byung-Hak;Jeong, Eun-Taik
    • Tuberculosis and Respiratory Diseases
    • /
    • v.42 no.3
    • /
    • pp.314-321
    • /
    • 1995
  • Background: Flow cytometric study has been used to measure the DNA content of solid tumors for the last decade. DNA ploidy is an important property commonly measured by flow cytometry. The possibility to study archival paraffin-embedded tumors has hastened an appreciation of prognostic utility of this method. The aim of this study is to look for biologic prognostic indicator for survival time of patients with small cell carcinoma of lung in addition to the well known clinical prognostic factors. Method: DNA ploidy was measured by flow cytometric method using tumor cells isolated from paraffin embedded tissue. To evaluate the prognostic significance, DNA ploidy of small cell lung cancer was analysed in 42 patients who died after receiving anticancer chemotherapy. Results: 1) Mean survival time of all patients was 190(${\pm}156$) days. Survival time was shortened, when TNM stage and PS scale were advanced. 2) 62% of all patients was DNA aneuploidy. DNA ploidy had nothing to do with advance of TNM stage and PS scale. 3) Mean survival time of aneuploid tumor was significantly shorter($138{\pm}90$ days) than that of diploid tumors($272{\pm}197$ days).(p<0.001) 4) To exclude the influence of clinical prognostic factors such as TNM stage and PS scale, the analysis was restricted to subgroups of identical stage. We were able to find the same tendency. Conclusion: DNA ploidy is an independent prognostic factor in small cell lung cancer.

  • PDF

Prognostic Value of Leptin in Terminally Ill Cancer Patients (말기암환자의 여명 예측 요인, 혈중 렙틴 농도의 효과)

  • Hong, Ji-Hyun;Lee, So-Jin;Kwak, Sang-Mi;Choi, Youn-Seon;Lee, June-Yeong
    • Journal of Hospice and Palliative Care
    • /
    • v.15 no.2
    • /
    • pp.99-107
    • /
    • 2012
  • Purpose: Most terminally ill cancer patients die from cancer anorexia-cachexia syndrome. This study evaluated a prognostic role of plasma leptin levels in terminally ill cancer patients. Methods: This study enrolled 69 terminally ill cancer patients who were aged above 20 years old from July 2009 to July 2010. For univariate analysis, an association between leptin levels and patient's characteristics or other variables was examined using Spearman's correlation analysis, Wilcoxon's rank-sum test or Kruskal-Wallis test, as appropriately. For multivariable analysis, Cox's proportional hazard regression model was used to evaluate a clinical significance of plasma leptin levels as a prognostic factor and to determine factors which affect the risk of death in terminally ill cancer patients. Results: A statistically significant positive correlation between plasma leptin levels and survival time was found. Univariate Cox's proportional hazard regression analyses also showed a moderately significant association between plasma leptin levels and survival time. However, after adjusting variables for sex, white blood cell counts, total bilirubin, AST, ALT, albumin and CRP levels, plasma leptin levels were not significantly associated with survival time. Conclusion: No significant association was found between plasma leptin levels and survival time in terminally ill cancer patients. However, this study suggested a prognostic value of plasma leptin levels in gastrointestinal cancer patients.

Comparative Analysis for Survival Period of Innovative SMEs and General SMEs (혁신형 중소기업과 일반 중소기업의 생존기간 비교분석)

  • Lee, Jun-won
    • Asia-Pacific Journal of Business Venturing and Entrepreneurship
    • /
    • v.18 no.1
    • /
    • pp.225-236
    • /
    • 2023
  • Policy implications were derived by comparing/analyzing innovative SMEs and general SMEs that obtained innovation certification from 2015 to 2021 in terms of survival period. Work experience, scale (employment, capital and debt size, sales and operating profit) Korean standard industry classification (2 digit) was used to select general SMEs similar to innovative SMEs. Survival period was calculated by defining suspension, closure and overdue equivalent to default as events. As a result of the survival analysis, innovative SMEs showed a 9.8% reduction in the risk of delinquency compared to general SMEs, indicating that the survival period of innovative SMEs was significantly longer. In addition, it was found that the work experience and size (employment, capital) of SMEs had a positive effect on the survival period, but debt had a negative effect on the survival period. This means that the innovation certification system centered on innovation capabilities and future growth potential is a significant indicator in terms of survival period. As a result, it was concluded that the benefits and support policies provided by the innovation certification system need to be more systematic and sophisticated by reflecting the work experience and industry for the actual growth and survival of SMEs.

  • PDF

The effects of adjuvant therapy and prognostic factors in completely resected stage IIIa non-small cell lung cancer (비소세포 폐암의 근치적 절제술 후 예후 인자 분석 및 IIIa 병기에서의 보조 요법의 효과에 대한 연구)

  • Cho, Se Haeng;Chung, Kyung Young;Kim, Joo Hang;Kim, Byung Soo;Chang, Joon;Kim, Sung Kyu;Lee, Won Young
    • Tuberculosis and Respiratory Diseases
    • /
    • v.43 no.5
    • /
    • pp.709-719
    • /
    • 1996
  • Background: Surgical resection is the only way to cure non-small cell lung cancer(NSCLC) and the prognosis of NSCLC in patients who undergo a complete resection is largely influenced by the pathologic stage. After surgical resection, recurrences in distant sites is more common than local recurrences. An effective postoperative adjuvant therapy which can prevent recurrences is necessary to improve long tenn survival Although chemotherapy and radiotherapy are still the mainstay in adjuvant therapy, the benefits of such therapies are still controversial. We initiated this retrospective study to evaluate the effects of adjuvant therapies and analyze the prognostic factors for survival after curative resection. Method: From 1990 to 1995, curative resection was perfomled in 282 NSCLC patients with stage I, II, IIIa, Survival analysis of 282 patients was perfonned by Kaplan-Meier method. The prognostic factors, affecting survival of patients were analyzed by Cox regression model. Results: Squamous cell carcinoma was present in 166 patients(59%) ; adenocarcinoma in 86 pmients(30%) ; adenosquamous carcinoma in II parients(3.9%); and large cell undifferentiated carcinoma in 19 patients(7.1%). By TNM staging system, 93 patients were in stage I; 58 patients in stage II ; and 131 patients in stage rna. There were 139 postoperative recurrences which include 28 local and 111 distant failures(20.1% vs 79.9%). The five year survival rate was 50.1% in stage I ; 31.3% in stage II ; and 24.1% in stage IIIa(p <0.0001). The median survival duration was 55 months in stage I ; 27 months in stage II ; and 16 months in stage rna. Among 131 patients with stage rna, the median survival duration was 19 months for 81 patients who received postoperative adjuvant chemotherapy only or cherne-radiotherapy and 14 months for the other 50 patients who received surgery only or surgery with adjuvant radiotherapy(p=0.2982). Among 131 patients with stage IIIa, the median disease free survival duration was 16 months for 21 patients who received postop. adjuvant chemotherapy only and 4 months for 11 patients who received surgery only(p=0.0494). In 131 patients with stage IIIa, 92 cases were in N2 stage. The five year survival rate of the 92 patients with N2 was 25% and their median survival duration was 15 months. The median survival duration in patients with N2 stage was 18 months for those 62 patients who received adjuvant chemotherapy and 14 months for the other 30 patients who did not(p=0.3988). The median survival duration was 16 months for those 66 patients who received irradiation and 14 months for the other 26 patients who did not(p=0.6588). We performed multivariate analysis to identify the factors affecting prognosis after complete surgical resection, using the Cox multiple regression model. Only age(p=0.0093) and the pathologic stage(p<0.0001) were significam prognostic indicators. Conclusion: The age and pathologic stage of the NSCLC parients are the significant prognostic factors in our study. Disease free survival duration was prolonged with statistical significance in patients who received postoperative adjuvant chemotherapy but overall survival duration was not affected according to adjuvant therapy after surgical resection.

  • PDF

Analysis of mortality after death of spouse in relation to duration of bereavement and dependence relation between married couple -using married couples data from survivor's pension of National Pension Service- (부부의 사망시차 및 생존기간의 종속관계 분석 -국민연금의 유족연금 데이터를 이용한 연구-)

  • Baek, HyeYoun;Han, Jeonglim;Lee, Hangsuck
    • Journal of the Korean Data and Information Science Society
    • /
    • v.26 no.4
    • /
    • pp.931-946
    • /
    • 2015
  • Many multiple life insurance products consider benefits that are contingent on the combined survival status of two lives. To value premiums of the insurance products accurately, we need to consider the impact of the survivorship of one life on another. To show a dependence relation between married couple, we calculate correlation coefficients by using married couples data from National Pension Service and the results show some positive dependence between them. Moreover, by analyzing the death after bereavement, we find a evidence that mortality rates increase after the death of a spouse and, in addition, that this phenomenon, the broken-heart syndrome, diminishes over time. The results of this study can support the method to calculate the premium of multiple life insurance reflecting more realistic joint mortality rates.

Surgical Treatment for Metastatic Pulmonary Sarcoma (폐전이 골 연부조직 육종에 대한 외과적 치료)

  • 박재길;이선희
    • Journal of Chest Surgery
    • /
    • v.30 no.12
    • /
    • pp.1214-1218
    • /
    • 1997
  • The therapeutic results of pulmonary resection for metastatic bone and soft tissue sarcomas were analyzed. From 1986 to 1996, 14 patients(11 male and 3 female) underwent 15 pulmonary resections for metastatic sarcomas. One(7.1%) patient had 2 thoracotomies for recurrences. The number of metastatic tumors were from one to five. The primary malignant tumors were from bone in 4 and from soft tissues in 10. Mean survival time after thoracotomy was 29.2 months, and Kaplan-Meier's 5-year survival rate from the first metastasectomy was 33.2%. Three patients who had the tumor free interval period over 3 years were alive(mean survival period 52.6 months), whereas eleven patients of the less than 3 years were dead with disease(mean survival period 17.3 months). These results suggested that pulmonary. metastasectomy in bone and soft tissue sarcoma may prolong the survival rate.

  • PDF

The Effects of Plasma Endotoxin Level on Survival Time of Terminally Ill Cancer Patients (말기암환자에서 혈장 내독소 농도가 생존기간에 미치는 영향)

  • Lee, Jin-Ah;Yoon, Ho Min;Choi, Youn Seon;Yeon, Jong Eun;Lee, June Young
    • Journal of Hospice and Palliative Care
    • /
    • v.17 no.2
    • /
    • pp.57-65
    • /
    • 2014
  • Purpose: Since most terminally ill cancer patients die of multiple organ failure, plasma endotoxin concentration levels may be used to predict the life expectancy. This study was performed to evaluate the clinical significance of endotoxin level in plasma as a prognostic factor for survival in patients with terminal cancer. Methods: This study was conducted with 56 terminally ill cancer patients, above 20 years old, from April 2009 through October 2009. Demographic characteristics, Karnofsky performance status, and survival time were evaluated. We analyzed blood levels of white blood cell hemoglobin, hematocrit, aspartate aminotransferase, alanine aminotransferase, c-reactive protein, total bilirubin and endotoxin in each patient. Results: We considered following variable for univariate analysis: plasma endotoxin level, sex, age, WBC, hemoglobin, hematocrit, AST, ALT, total bilirubin, CRP and severity of pain. Univariate analysis did not show a significant association between plasma endotoxin level and survival time. However, in a multivariate analysis with factors that were found to be significantly associated with survival sex, WBC count and total bilirubin level in univariate analysis, high levels of plasma endotoxin and short survival time were significantly related. Conclusion: Plasma endotoxin level could be used as a prognostic factor to predict the life expectancy of terminally ill cancer patients.